Explore the intricacies of the FDA's new classification for DNA-based tests measuring minimal residual disease in hematological malignancies. Learn how the shift to Class II with special controls impacts safety, effectiveness, and patient access, reducing regulatory...
2024
Showing 37–45 of 518 resultsSorted by latest
-
Compliance with OPM’s Suitability and Fitness Rule
$49.99 -
Trichloroethylene (TCE) Regulation: Compliance and Implementation under TSCA
$129.99 -
Health Data, Technology, and Interoperability: Protecting Care Access
$129.99 -
HUBZone Program Regulation Amendments for Small Businesses
$129.99 -
Ensuring Safe Air Travel for Passengers Using Wheelchairs
$129.99 -
SNAP Final Rule Compliance Course
$129.99 -
Comprehensive Guide to Federal Leave Categories
$129.99 -
Comprehensive Training on the Final Rule for Select Agents and Toxins
$49.99 -
Bureau of Prisons Rule on Attorney-Client Visits
$9.99